FI921134A0 - Oral antikoagulant- blodplaettinhibitorlaogdosformulering. - Google Patents

Oral antikoagulant- blodplaettinhibitorlaogdosformulering.

Info

Publication number
FI921134A0
FI921134A0 FI921134A FI921134A FI921134A0 FI 921134 A0 FI921134 A0 FI 921134A0 FI 921134 A FI921134 A FI 921134A FI 921134 A FI921134 A FI 921134A FI 921134 A0 FI921134 A0 FI 921134A0
Authority
FI
Finland
Prior art keywords
oral anticoagulant
blodplaettinhibitorlaogdosformulering
combination products
recurrent
preferrably
Prior art date
Application number
FI921134A
Other languages
English (en)
Other versions
FI921134A (fi
Inventor
William Joseph Addicks
Joseph A Mollica
Gary Howard Slatko
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of FI921134A0 publication Critical patent/FI921134A0/fi
Publication of FI921134A publication Critical patent/FI921134A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
FI921134A 1989-09-18 1992-03-17 Oral antikoagulant- blodplaettinhibitorlaogdosformulering. FI921134A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/408,394 US5041430A (en) 1989-09-18 1989-09-18 Oral anticoagulant/platelet inhibitor low dose formulation
PCT/US1990/004950 WO1991004031A1 (en) 1989-09-18 1990-09-05 Oral anticoagulant/platelet inhibitor low dose formulation

Publications (2)

Publication Number Publication Date
FI921134A0 true FI921134A0 (fi) 1992-03-17
FI921134A FI921134A (fi) 1992-03-17

Family

ID=23616120

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921134A FI921134A (fi) 1989-09-18 1992-03-17 Oral antikoagulant- blodplaettinhibitorlaogdosformulering.

Country Status (22)

Country Link
US (1) US5041430A (fi)
EP (1) EP0493408B1 (fi)
JP (1) JPH05501109A (fi)
KR (1) KR950008307B1 (fi)
AT (1) ATE137972T1 (fi)
AU (1) AU635881B2 (fi)
CA (1) CA2065347A1 (fi)
CZ (1) CZ454090A3 (fi)
DE (1) DE69027036D1 (fi)
FI (1) FI921134A (fi)
GR (1) GR1001131B (fi)
HU (1) HUT62488A (fi)
IE (1) IE903356A1 (fi)
IL (1) IL95721A (fi)
LV (1) LV10050B (fi)
MA (1) MA21953A1 (fi)
MX (1) MX173727B (fi)
NO (1) NO920946D0 (fi)
NZ (1) NZ235337A (fi)
PT (1) PT95343B (fi)
WO (1) WO1991004031A1 (fi)
ZA (1) ZA907431B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
CA2100836C (en) * 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
AU5787996A (en) * 1995-04-19 1996-11-07 Lipoprotein Technologies, Inc. Compositions, kits, and methods for administration of antilipemic and anti-platelet aggregation drugs
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6121249A (en) * 1998-07-01 2000-09-19 Donald L. Weissman Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
US8173164B2 (en) * 1999-06-17 2012-05-08 Gruenenthal Gmbh Oral administration forms for administering a fixed tramadol and diclofenac combination
AU2002226986A1 (en) * 2000-12-01 2002-06-11 Rheologics, Inc. In vivo delivery methods and compositions
WO2002079778A2 (en) * 2001-03-28 2002-10-10 Rheologics, Inc. In vivo delivery methods and compositions
US20050119238A1 (en) * 2002-03-01 2005-06-02 Baron John A. Compositions and methods for preventing sporadic neoplasia in colon
EP1589930A2 (en) * 2003-01-08 2005-11-02 Flacco-Nesselroad Family Trust Combination therapy for anticoagulation
CZ20032854A3 (cs) * 2003-10-17 2005-05-18 Pliva - Lachema A.S. Způsob přípravy dávkových jednotek pevné lékové formy obsahujících jako účinnou látku sodnou sůl warfarinu
MXPA06004327A (es) * 2003-10-20 2007-01-26 Teva Pharma Composiciones y forma de dosificacion para el efecto retardado de levodopa.
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
AU2005245026B2 (en) * 2004-05-21 2010-07-01 Accu-Break Technologies, Inc. Immediate release pharmaceutical tablets with height greater than width
US20060003000A1 (en) * 2004-07-01 2006-01-05 Lawrence Solomon Adhesively bonded dosage form
US8758814B2 (en) 2004-10-08 2014-06-24 Mcneil-Ppc, Inc. Chewable enteric coated aspirin tablets
US8057820B2 (en) * 2004-10-08 2011-11-15 Mcneil-Ppc, Inc. Enteric coated aspirin granules comingled with binder
JP4613590B2 (ja) 2004-11-16 2011-01-19 セイコーエプソン株式会社 実装基板及び電子機器
US20100034878A1 (en) * 2006-12-19 2010-02-11 Bussey Henry I Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy
WO2008156691A1 (en) * 2007-06-19 2008-12-24 Duke University Anitcoagulants as antifouling agents
DE102008014237A1 (de) * 2008-03-14 2009-09-17 J. Rettenmaier & Söhne Gmbh + Co. Kg Direktverpressbares Tablettierhilfsmittel
JP5529404B2 (ja) * 2008-09-05 2014-06-25 東和薬品株式会社 アスピリン腸溶錠
WO2012060847A1 (en) * 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
LV14606B (lv) 2011-05-17 2013-01-20 Tetra, Sia Jauns XII faktora inhibitors
CZ2012435A3 (cs) * 2012-06-27 2013-11-13 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta Zpusob prípravy pevné lékové formy se sodnou solí warfarinu ve forme klathrátu izopropanolu
JP6304751B2 (ja) * 2014-03-24 2018-04-04 日新製薬株式会社 ワルファリン含有固形製剤及びその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2265273A1 (en) * 1974-03-29 1975-10-24 Zootherap Laboratoires Anticoagulant-contg. rodenticidal compsn. - contg. (acetyl) salicyclic acid or salt as synergist
LU77353A1 (fi) * 1977-05-16 1979-01-19
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
DE2860430D1 (en) * 1977-10-08 1981-02-26 Beecham Group Ltd Antithrombotic compositions containing benzisothiazolones
SU1050708A1 (ru) * 1981-04-27 1983-10-30 Горьковский государственный медицинский институт им.С.М.Кирова Способ лечени гиперкоагул ции при коронарном атеросклерозе
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
EP0169465B1 (de) * 1984-07-21 1990-02-28 Hoechst Aktiengesellschaft Kombinationspräparat aus Pyrimido-pyrimidinen und O-Acetylsalicylsäure bzw. deren pharmakologisch verträglichen Salzen und dessen Verwendung

Also Published As

Publication number Publication date
AU6330690A (en) 1991-04-18
ZA907431B (en) 1992-05-27
KR950008307B1 (ko) 1995-07-27
US5041430A (en) 1991-08-20
LV10050A (lv) 1994-05-10
PT95343B (pt) 1998-06-30
IL95721A (en) 1995-07-31
GR900100702A (en) 1992-01-20
PT95343A (pt) 1991-08-14
CZ454090A3 (en) 1996-11-13
AU635881B2 (en) 1993-04-01
ATE137972T1 (de) 1996-06-15
MX173727B (es) 1994-03-24
IL95721A0 (en) 1991-06-30
MA21953A1 (fr) 1991-04-01
EP0493408A4 (en) 1992-10-07
IE903356A1 (en) 1991-04-10
GR1001131B (el) 1993-04-28
KR920703046A (ko) 1992-12-17
LV10050B (en) 1995-02-20
NO920946L (no) 1992-03-11
NO920946D0 (no) 1992-03-11
EP0493408B1 (en) 1996-05-15
WO1991004031A1 (en) 1991-04-04
HUT62488A (en) 1993-05-28
JPH05501109A (ja) 1993-03-04
CA2065347A1 (en) 1991-03-19
NZ235337A (en) 1993-05-26
EP0493408A1 (en) 1992-07-08
DE69027036D1 (de) 1996-06-20
FI921134A (fi) 1992-03-17

Similar Documents

Publication Publication Date Title
FI921134A (fi) Oral antikoagulant- blodplaettinhibitorlaogdosformulering.
ATE279922T1 (de) Behandlung von zns-wirkungen des hiv mit vx-478, allein oder kombiniert mit azt oder 3tc
BR9004553A (pt) Embalagem de sutura
FI904101A0 (fi) 17b-acyl-4-aza-5a-androst-1-en-3-on- som 5a-reduktasinhibitorer.
DE69008664D1 (de) Bestrahlung von bluterzeugnissen.
DE58903875D1 (de) Distyrylbiphenylverbindungen.
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
FI904729A0 (fi) Inhibitorer av retrovirala proteaser.
DE69419295T2 (de) Zweifach gegossenes Produkt
FI903178A0 (fi) Oeverdragen produkt.
DE59308079D1 (de) Doppelschubzentrifuge
NO894158D0 (no) Curcumin ved paavisning av varsling av cyanid-oppblandete naeringsmidler.
NO901422D0 (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
FI902869A0 (fi) Vegetabel produkt.
AR240016A1 (es) Procedimiento de preparacion de una composicion para el tratamiento de flebectasias.
ES1010967Y (es) Etiqueta doble.
IT8835514V0 (it) Gioco di pronostici basato sulle quotazioni dei titoli azionari
IT216152Z2 (it) Chiusura di stivale da motocross.
ES1011155Y (es) Colgador de doble percha.
NO881449D0 (no) Anordning ved laksemaere.
FI882012A (fi) Ledstruktur foer en tippdoerr.
IT8950802V0 (it) Sterilizza scarpe
MX16751A (es) Procedimiento para la preparacion de nuevos compuestos heterociclicos condensados y productos obtenidos mediante el mismo.
ES1009514Y (es) Calzado sanitario.
ES1009504Y (es) Cerrajo de doble accion.